Results 291 to 300 of about 3,407,318 (341)

Antiplatelet Agents

2007
Garvan Kane, Yong-Mei Cha
openaire   +2 more sources

Antiplatelet Aggregating Agents

1984
Arterial or venous occlusion by blood clot are common occurrences in old age and the incidence rises as age progresses. They both give rise to considerable morbidity as well as mortality. The prevention of thrombosis and its consequences would inevitably promote and maintain health in old people.
openaire   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Antiplatelet drugs

Reactions weekly
Keith Kelly
semanticscholar   +1 more source

Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis.

Obstetrics and Gynecology, 2017
E. O. V. van Vliet, Lisa Askie, B. Mol, M. Oudijk   +3 more
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Antiplatelet Agents

2008
Farzin Beygui, Gilles Montalescot
openaire   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease

Expert Opinion on Drug Safety, 2017
Ashwin S. Nathan, Sounok Sen, R. Yeh
semanticscholar   +1 more source